Elexacaftor/tezacaftor/ivacaftor (ETI) therapy modifies the expression of interferon beta and inflammatory genes in the airways of adult patients with cystic fibrosis: a pilot study. - Bitossi C; Frasca F; D'Auria A; Fracella M; Radocchia G; Trancassini M; Petrarca L; La Regina D; Troiani P; Gentile M; Pietropaolo V; Midulla F; et al. (Molecular and cellular biochemistry, 2025)